A phase III trial evaluated intermediate-dose cytarabine plus granulocyte-colony stimulating factor (G-CSF) vs G-CSF alone prior to autoSCT in multiple myeloma.
Lauren M. Dembeck
Advertisement
Articles by Lauren M. Dembeck
Advertisement
Latest Updated Articles
Combination Therapy Enhances Stem Cell Mobilization in Patients With Multiple MyelomaPublished: April 16th 2019 | Updated:
Advertisement
Advertisement
